---
type: earnings-call
company: "UnitedHealth Group"
ticker: UNH
quarter: Q3
fiscal_year: 2025
source: Yahoo Finance
---

## Summary
UnitedHealth Group reported solid revenues and EPS, driven by domestic membership expansion and strategic investments. They face challenges from Medicare Advantage membership contraction, Medicaid funding pressures, and elevated medical cost trends. The company is implementing strategies to improve OptumHealth's performance, focus on value-based care, and expand AI-driven solutions.

## Guidance
{'medicare_advantage_membership_contraction': 'approximately 1 million members', 'optumhealth_margin_2025': 'just under 3%', 'commercial_margins_target_2027': '7% to 9%', 'commercial_margins_current_2025': '3% to 5%', 'medicaid_margin_recovery': '2% margin over an 18- to 24-month period', 'full_rebate_pass_through_percentage_2027': '95%'}

## Strategic Initiatives
['Refocusing OptumHealth on value-based care with leadership changes and market exits.', 'Expanding full rebate pass-through arrangements to 95% of OptumRx customers by 2027.', 'Investing in AI-first products within OptumInsight, such as Optum Real and Optum Integrity One.', 'Focus on margin improvement within UnitedHealthcare in 2026.', 'Refocusing OptumHealth on value based care']

## Risks
['Medicare Advantage membership contraction due to benefit adjustments and plan exits.', 'Medicaid funding pressures and states not funding in line with actual cost trends.', 'Elevated medical cost trends, particularly in Medicare Advantage (7.5%) and Med Sup (over 11%).', 'Headwinds from Medicare cuts.', 'Operating inconsistencies within OptumHealth due to rapid expansion.']

---
## Transcript
This article first appeared onGuruFocus.

Adjusted Earnings Per Share (EPS):$2.92, slightly ahead of expectations.

Revenue:Over $113 billion, reflecting 12% year-over-year growth.

Domestic Membership Expansion:Over 780,000 lives year-to-date, ending with more than 50 million total domestic members.

Medical Care Ratio:89.9% in the quarter, compared to 85.2% in the same quarter last year.

Operating Cost Ratio:13.5%, reflecting larger investments in technology and people.

Cash Flow:Operating cash flow from operations of $5.9 billion.

Debt-to-Capital Ratio:Stable at 44.1%.

Medicare Advantage Membership:Expected contraction of approximately 1 million members.

ACA Rate Increases:Average rate increases of over 25% submitted.

OptumHealth Margin:Expected to end 2025 with margins just under 3%.

OptumRx Revenue Growth:Double-digit revenue growth in pharmacies.

Warning! GuruFocus has detected 4 Warning Sign with UNH.

Is UNH fairly valued? Test your thesis with our free DCF calculator.

Release Date: October 28, 2025

For the complete transcript of the earnings call, please refer to thefull earnings call transcript.

UnitedHealth Group Inc (NYSE:UNH) reported adjusted earnings per share of $2.92, slightly ahead of expectations, reflecting steady execution and strategic investments.

The company delivered revenues of over $113 billion, marking a 12% year-over-year growth driven by domestic membership expansion.

UnitedHealth Group Inc (NYSE:UNH) is on track to drive solid operating earnings growth from margin improvement within UnitedHealthcare in 2026.

OptumHealth is refocusing on its original mission around value-based care, with significant leadership changes and strategic market exits to improve performance.

OptumRx continues to perform well with double-digit revenue growth and strong customer retention, with plans to expand full rebate pass-through arrangements to 95% of customers by 2027.

Medical cost trends remain historically high, with a full-year trend of approximately 7.5% in Medicare Advantage and over 11% in Med Sup offerings.

UnitedHealth Group Inc (NYSE:UNH) expects membership contraction of approximately 1 million members in total Medicare Advantage due to benefit adjustments and plan exits.

The Medicaid segment faces challenges with states not funding in line with actual cost trends, leading to insufficient coverage for health needs.

OptumHealth's rapid expansion led to operating inconsistencies, requiring a return to a more integrated and dedicated value-based care provider model.

The company faces external challenges, including continued headwinds from Medicare cuts and Medicaid funding pressures, impacting overall performance.

Q: Can you provide an updated view on the revenue breakdown within OptumHealth, specifically regarding capitated premiums and fee-for-service billings?A: Patrick Conway, CEO of Optum, explained that 65% of OptumHealth's revenue comes from value-based care (VBC), with two-thirds of this from UnitedHealthcare. The remaining revenue is from care delivery fee-for-service and payer services. Krista Nelson, CEO of UnitedHealthcare Community & State, emphasized their commitment to achieving a 6% to 8% margin in the long term, with a focus on value-based care.

Q: What is the competitive position of OptumInsight, and where are investments needed?A: Sandeep Dadlani, CEO of Optum Insight, stated that OptumInsight has a strong competitive position with significant potential for growth. Investments are focused on AI-first products, such as Optum Real and Optum Integrity One, which have shown promising results in streamlining processes and improving productivity. The goal is to evolve traditional services into AI-first platforms.

Q: Can you confirm the commercial margins target for 2027 and the current baseline for 2025?A: Timothy Noel, CEO of UnitedHealthcare, confirmed that the target for commercial margins is 7% to 9% by 2027. For 2025, the margins are estimated to be in the 3% to 5% range. The company aims to make meaningful progress in 2026 through pricing actions and cost control.

Q: What are the expectations for Medicare Advantage membership in 2026, and how does this compare to industry growth?A: Robert Hunter, CEO of Government Programs & Head of Medicare Insurance, stated that UnitedHealth Group expects a contraction of approximately 1 million members in Medicare Advantage for 2026, due to product exits and disciplined pricing. Industry growth is expected to be flat in 2025, with potential for growth in 2027 and beyond, despite current funding cuts and medical trend pressures.

Q: How is UnitedHealth Group addressing the challenges in Medicaid, and what is the outlook for margin recovery?A: Mike Cotton, head of the Medicaid Insurance Segment, indicated that Medicaid margins are expected to be breakeven in 2025 and decline further in 2026 due to funding dislocation and elevated medical costs. However, the company anticipates a return to a 2% margin over an 18- to 24-month period as they collaborate with states and address cost drivers.

For the complete transcript of the earnings call, please refer to thefull earnings call transcript.
